• BMN 673 (Talazoparib): Unveiling PARP1/2 Inhibition Dynam...

  2025-09-29

  Explore the advanced scientific mechanisms of BMN 673 (Talazoparib), a potent PARP1/2 inhibitor, with a focus on PARP-DNA complex trapping and the molecular interplay in homologous recombination deficient cancer treatment. This article provides unique, mechanistically detailed insights and future applications, setting it apart from existing reviews.

• BMN 673 (Talazoparib): Precision PARP1/2 Inhibition for D...

  2025-09-28

  Explore the advanced scientific rationale behind BMN 673 (Talazoparib), a potent PARP1/2 inhibitor, with a unique focus on its molecular selectivity, clinical research utility, and the latest mechanistic insights into DNA repair deficiency targeting. Discover how this selective PARP inhibitor for cancer therapy is shaping translational oncology and beyond.

• BMN 673 (Talazoparib): Unraveling Selective PARP Inhibito...

  2025-09-27

  Explore the advanced mechanism of BMN 673 (Talazoparib), a potent PARP1/2 inhibitor, with new insights into PARP-DNA complex trapping and BRCA2-RAD51 regulation. This in-depth analysis offers a unique perspective on homologous recombination deficient cancer treatment and future research directions.

• BMN 673 (Talazoparib): Unveiling Precision in PARP1/2 Inh...

  2025-09-26

  Explore the advanced mechanisms of BMN 673 (Talazoparib), a potent PARP1/2 inhibitor, with a focus on its unique PARP-DNA complex trapping and the molecular interplay with BRCA2-RAD51 in homologous recombination deficient cancer treatment. Discover how this agent is redefining selectivity and efficacy in cancer research.

• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit: Transfor...

  2025-09-25

  Discover how the HyperScribe T7 High Yield Cy3 RNA Labeling Kit advances in vitro transcription RNA labeling for next-generation fluorescent RNA probe synthesis. This article uniquely explores the molecular mechanisms, optimization strategies, and frontier applications in selective mRNA delivery and cancer research.

• Unlocking Precision RNA Synthesis: HyperScribe™ T7 High Y...

  2025-09-24

  Discover how the HyperScribe T7 High Yield RNA Synthesis Kit empowers advanced in vitro transcription for probing mitochondrial metabolism and post-translational regulation. Explore distinct, in-depth strategies for generating functional RNA for cutting-edge biochemical research.

• Asunaprevir (BMS-650032): Mechanistic Insights and Emergi...

  2025-09-23

  Explore the mechanistic action and research applications of Asunaprevir (BMS-650032), a potent HCV NS3 protease inhibitor with broad genotype coverage and hepatotropic drug distribution. This article provides a rigorous analysis for scientists investigating HCV RNA replication inhibition and antiviral strategies for hepatitis C.

• Several approved and or experimental drugs

  2025-04-22

  

  Several approved and/or experimental drugs, together with natural compounds, have been reported to induce autophagy in different cancer types [70], [71], [72] (Table 1). In the next paragraphs, we will review more in detail a group of these agents selected in relation to their promising future outco

• br Regulation of V ATPase assembly

  2025-04-21

  

  Regulation of V-ATPase assembly in response to changes in amino InstaBlue Protein Stain Solution levels A central regulator of cell growth and metabolism is mTORC1 [38]. mTORC1 integrates signals from nutrient availability and growth factor receptors to control such processes as protein and lipi

• Protein protein interaction networks are an

  2025-04-19

  

  Protein–protein interaction networks are an important ingredient for the system-level understanding of cellular processes. Such networks can be used for filtering and assessing functional genomics data and for providing an instinctive platform for annotating structural, functional and evolutionary p

• Previously using a P lacZ reporter gene

  2025-04-19

  

  Previously, using a P-lacZ reporter gene system, it has been shown that the β-galactosidase activity was 9-fold higher in the stationary phase Sulfo-NHS-Biotin when compared with those of the exponential phase [15]. Furthermore, inositol supplementation did not have a major effect on the expression

• Introduction The MMR system keeps the fidelity

  2025-04-19

  

  Introduction The MMR system keeps the fidelity of replication by repairing replication errors such as base-base mispairs and insertions/deletions. It plays a substantial role in restoring the fidelity of DNA and contributing to genome integrity [1]. The components of MMR are conserved in a broad ra

• In our studies of leucine and BCH in pancreatic

  2025-04-19

  

  In our studies of leucine and BCH in pancreatic islets and clonal insulin cell lines, we noticed that leucine was a slightly stronger stimulant of insulin release. Previous studies showed that leucine can be metabolized to CO2[11], [12], [13], [14] and can increase acetoacetate in pancreatic islets

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2025-04-19

  

  In the present study we sought to decipher the role of ATP-citrate lyase and of the mitochondrial NADH-dependent Mae in the oleaginous yeast Y. lipolytica. Indeed, although this yeast is one of the major models for lipid metabolism, the function of these enzymes is still not clear. As the study of t

• Illustrated in is the protocol we applied for the screens

  2025-04-19

  

  Illustrated in is the protocol we applied for the screens of novel furoic acids as ACL inhibitors. We constructed our furan carboxylate library that contained 1446 2-furoic Y-27632 dihydrochloride derivatives and 501 3-furoic acid derivatives by performing substructural searches of the ZINC datab

16272 records 2/1085 page Previous Next 12345 下5页 Last page